Proassurance (PRA) Cash & Equivalents (2009 - 2026)

Proassurance has disclosed Cash & Equivalents across 18 years of filings, most recently posting $14.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 67.72% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $14.1 million (down 67.72% YoY), while the FY2025 annual figure was $36.5 million, down 33.5% from the prior year.
• Cash & Equivalents eased to $14.1 million in Q1 2026, from $36.5 million in the prior quarter.
• Over the last five years, Cash & Equivalents for PRA reached as high as $72.1 million in Q1 2022 and fell as low as $14.1 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $45.3 million (2024), against an average of $47.1 million.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 79.61% — and 2023, when it jumped 119.96%.
• A 5-year view of Cash & Equivalents shows it stood at $30.0 million in 2022, then jumped by 119.96% to $65.9 million in 2023, then declined by 16.72% to $54.9 million in 2024, then tumbled by 33.5% to $36.5 million in 2025, then tumbled by 61.49% to $14.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $14.1 million, $36.5 million, and $54.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.